Does RAMUCIRUMAB Cause Performance status decreased? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Performance status decreased have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 0.2% of all adverse event reports for RAMUCIRUMAB.
10
Reports of Performance status decreased with RAMUCIRUMAB
0.2%
of all RAMUCIRUMAB reports
6
Deaths
3
Hospitalizations
How Dangerous Is Performance status decreased From RAMUCIRUMAB?
Of the 10 reports, 6 (60.0%) resulted in death, 3 (30.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMUCIRUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which RAMUCIRUMAB Alternatives Have Lower Performance status decreased Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE